Top Stem Cells Conference | Stem Cells Congress | Tissue Engineering Conference | Regenerative Medicine Conference | Stem Cells Meetings | Stem Cells Research | Stem Cells Summit |Paris | France | London | UK | USA | Europe | Middle East

Theme:

Stem Cell Congress - 2023

Renowned Speakers

Dr Kalle Levon
New York University Tandon School of Engineering
USA

Mark Slevin
Manchester Metropolitan University
UK

Paul Y F Lee
University of Lincoln
UK

Nadia Rumman
Cardiff University
UK

Khalid Shah
Harvard Medical School USA
USA

Nadja Zeltner
University of Georgia
USA

MinYoung Kim
CHA University, Republic of Korea
South Korea

Joel I Osorio
Westhill University School of Medicine
Mexico

Jehad Zweiri
University of Liverpool School of Medicine
UK

Kristine Freude
Brainstem
Denmark

Farzin Farzaneh
Kingâ€™s College London
UK

Hongjun Wang
Medical University of South Carolina
USA

Whitney Yin
University of Texas Medical Branch
USA

Stem Cell Congress - 2023

A Hearty Welcome to All the Aspirants!!

We cordially invites you to attend the “18^th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research”, which is forthcoming in the month of October 16-17, 2023 at Paris, France.

Theme: "Recent Developments and New Innovations in the field of Stem Cells and Regenerative Medicine".

We invites all the participants from all across the globe to attend “18th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research”, on October 16-17, 2023 at Paris, France which includes prompt keynote presentations, poster presentations, and oral talks.

Stem cells are cells that have the potential to become many various or specialized cell types. Stem cells are often thought of as primitive, "unspecialized" cells that are ready to divide and become specialized cells of the body like liver cells, muscle cells, blood cells, and other cells with specific functions. Stem cells are referred to as "undifferentiated" cells because they have not yet committed to a developmental path that will form a specific tissue or organ. The process of changing into a specific cell type is known as differentiation. In some areas of the body, stem cells divide regularly to renew and repair the existing tissue.

This conference plays a Global platform for biomedical companies, start-ups, clinical research divisions, professionals, specialists, consultants, doctors, scholars and students to frame new relationship and strengthen the Knowledge. This is a great opportunity for all the delegates from Universities and Institutes to interact with the top grade world class Scientists. The particular participants can confirm their participation through Registrations. To explore More Regarding the Recent Research in Stem Cell its application attends Stem Cells Congress 2023.

We are one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia. Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business with 700+ peer-reviewed open access journals in basic science, health, and technology.

Stem Cells Congress 2023 envisage not less than 300 participants throughout the sphere with contemplated triggering keynote lectures, plenary sessions, Oral Demonstrations and Poster Presentations. The appearing ambassadors involve Editorial Board Members of related Transnational Journals. This is an incomparable prospect for the delegates from Universities and Organizations to act together with the world class Experts.

Stem Cells:
Stem cells are multipotent cells are capable of both self-renewal and multi-lineage differentiation, including muscle cells. The term stem cell originated in the context of two main embryological questions of that time first one is the continuity of the germ-plasm and the origin of the hematopoietic system. Bone-marrow is derived stem cells, endothelial progenitor cells and unique stem cells from fat are the foremost widely used for implantation into the injured myocardium. It has originally hypothetical that stem cells implanted into the myocardial milieu would differentiate into cardio myocytes to exchange those lost during the myocardial infarct. The encouraging results of the preclinical studies triggered that variety of clinical trials. The first clinical trials established the utility of somatic cell therapy to repair the injured myocardium. Animal studies confirmed that somatic cell transplantation was safe and potentially efficacious.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Tissue Engineering:
Many more mortality occurred thanks to less availability of organs and donors. Tissue engineering/ Regenerative medicine opens the trail to make and generate desired tissue, cells and also as Organs In Vitro to fight against the limitation and to make a replacement hope within the field of transplantation to fill the damaged and missing body parts while rehabilitation engineering helps to revive normal function. Spanning use of cell, pharmacological and bioengineering technologies, alongside physical modalities and exercise

• Whole organ engineering

• Extracellular matrix analog

• Auricular cartilage reconstruction

• Biomaterials and biopolymers for tissue engineering

• Hydrogels for tissue engineering

• Dermal tissue and Stem cell engineering

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Regenerative Medicine research and development:
Regenerative medicine is an interdisciplinary field that explore to develop the science and tools that can help to repair or replace damaged or diseased human cells or tissues to restore normal function, and holds the ensure of revolutioning treatment within the 21st century. It may involve the transplantation of stem cells, pro-genitor cells or tissue, stimulation of the body's own repair processes, or the use of cells as transmission-vehicles for therapeutic agents such as genes and cytokines. All the regenerative medicine strategies depend upon exploit, stimulating or guiding endogenous development or repair processes. According to some research, somatic cell research plays a central role in regenerative medicine, which also extends the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, biomaterials (scaffolds and matrices), chemical biology and nanotechnology. Promoting the somatic cell research, regenerative medicine and advanced therapeutics and many more broadly may be a priority for us and for the United Kingdom government.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Regenerative Therapy in Osteoarthritis
Osteoarthritis( OA) is the most common common disorder in the world. It generally affects the knee & elbow and current treatment options are limited and substantially focusing on symptom relief. It's now known that Osteoarthritis is the result of both biological and mechanical events that disrupt catabolic and anabolic processes in the joints. lately, exploration in regenerative therapeutics has been gaining further interest of its eventuality to restore the normal structure and functions of the following towel injury. The use of Mesenchymal Stem cells in knee Osteoarthritis seems promising as it's suitable to separate into a wide variety of cells, similar as myocytes, tendocytes and ligament cells. The thing is to use the body’s own form mechanisms in order to heal the tissues that were preliminarily irrecoverable. The available exploration on similar therapies, similar as mesenchymal stem cells, platelet rich tube, hyaluronic acid, and prolotherapy, further exploration is demanded to establish the use of these therapies for the treatment of knee OA.

3D Bio-Printing and Organ Printing:
3D Bio printing may be a sort of additive manufacturing that uses cells and other biocompatible materials as “inks”, also referred to as bio inks, to print living structures layer-by-layer which mimic the behaviour of natural living systems. Bio printed structures, like an organ-on-a-chip, are often wont to study functions of a person's body outside the body (in vitro), in 3D. The geometry of a 3D bio printed structure is more almost like that of a present biological system than an in vitro study performed in 2D, and may be more biologically relevant. It’s used most ordinarily within the fields of tissue engineering and bioengineering, and materials science. 3D bio printing is additionally increasingly used for pharmaceutical development and drug validation, and within the future are going to be used for medical applications in clinical settings – 3D printed skin grafts, bone grafts, implants, biomedical devices, and even full 3d printed organs are all active topics of bio printing research.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Cell and Gene Therapy:
Cells are the essential building blocks of all living things, and genes are often found deep within cells. Genes are small sections of DNA that carry genetic information and directions for creating proteins, which help build and maintain the body. Every person has around 20,000 genes and two copies of every of their genes one from each parent. Small variations in genes end in differences in people’s appearance and, potentially, health. Genetic diseases happen when a critical piece or whole section of DNA is substituted, deleted or duplicated. These changes are called genetic mutations. Some serious genetic diseases caused by genetic mutations are often passed to future generations.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Dental Stem Cell
Several millions of cells with stem cell properties have been originated from different parts of the tooth. Regenerative medicine is the process of replacing the human cells, tissues and various organs for therapeutic applications. The concept of regeneration in medical field is not new, but it has significantly advanced post discovery of stem cells and in recent times many of scientist have found its application in dentistry as the identification of Dental stem cells. The concept of tooth regeneration was not accepted initially, but after that ground-breaking work by stomatologist G. L. Feldman in the year 1932 showed the evidence of regeneration medicine in dental pulp under certain biological conditions. These include cells from the pulp of both exfoliated (children's) and adult teeth, from the periodontal tissue ligament that links the tooth root with the bone, from the tips of developing roots and tissue i.e. dental follicle that surrounds the interrupted tooth. This work introduced the biological-aseptic principle of tooth therapy to achieve pulp regeneration using dentine filling as building material for stimulating pulp regeneration. When Gronthos et al. identified and isolated odontogenic progenitor population in adult dental pulp. This type of cells was referred to as Dental Pulp Stem Cells (DPSCs). The discovery several researchers have reported varieties of dental stem cells

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Bio Banking:
Bio Banking is a process in which collection of samples from the body fluid or tissues for research use to improve health and diseases. Bio banks have become an important resource in medical research, supporting many types of contemporary research like genomics and personalized medicine. Other information’s, such as weight, height and any questions regarding health can also be recorded to provide the context for the samples. Often the samples are reserve for a long period of time or for several years, depending on the study, so that long term future research can be carried out. The researchers may follow up the health of the participants by looking towards their past and future medical records, only if people have given permission to do.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Stem Cells and Disease Modelling:
Human pluripotent stem cells (HPSCs) are useful model system for understanding the genetic basis of human cardiovascular diseases. HPSCs are often firmly genetically matched to patients with disease. Previously, only in unusual substance was it viable to review primary tissues like heart muscle and blood vessels obtained directly from living patients, and even in such circumstances, the quantity of tissue was limited. HPSCs produce a replacement approach that gives a unique opportunity to review human cells that are matched to the patients of interest. Because they will be propagated into very large numbers and differentiated into a spread of cell types that are relevant to cardiovascular diseases—including cardio myocytes, vascular endothelial and smooth muscle cells, and hepatocytes—HPSCs can in theory provide a limitless source of fabric with which to dissect the molecular support of the patient’s disease process within and beyond the circulatory system.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

COVID-19 and Convalescent Plasma:
The use of convalescent plasma (CP) collected from the previously infected individuals to passively transfer antibodies as to guard or treat human’s dates back almost 100 years. Results from small cases series during the prior SARS and MERS coronavirus outbreaks suggested that the Convalescent Plasma is safe and should confer clinical benefits, including faster viral approval, particularly when administered early within the disease course1. The overwhelming majority of patients who get over COVID-19 illness develop circulating antibodies to varied SARS-CoV-2 proteins 2-3 weeks following infection, which are detectable by ELISA or other quantitative assays and sometimes correlate with the presence of neutralizing antibodies.

Donations can occur as frequently as weekly for several months before antibody titers begin decreasing. Allowed donation frequency varies between blood centers. Listed below are some sites for referral of potential donors:

• AABB: Information about convalescent plasma donation and a feature that helps potential donors locate AABB-accredited donation sites.

• FDA Donate COVID-19 Plasma: Lists places to donate convalescent plasma for transfusion or for manufacturing of hyper immune globulin

• National COVID-19 Convalescent Plasma Project

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Effect of Aging on Stem Cells:
The functions of aged stem cells become impaired as the result of cell-intrinsic pathways and surrounding environmental changes with the sharp rise in aging- associated conditions, the need for effective regenerative drug strategies for the aged is more important than ever. Fortunately, rapid-fire advances in stem cell and regenerative medicine technologies continue to give us with a better understanding of the conditions that allows us to develop further effective curatives and individual technologies to more treat aged cases. Still, there's a big ethical concern regarding the use of mortal embryos to procure embryonic stem cells, and numerous countries nowadays circumscribe trials on embryos to the first 14days. The International Society for Stem Cell Research has issued guidelines advising experimenters across the globe to stick with this 14-days window. Even though, it seems that mortal stem cell exploration in the coming decade will probably bring enormous progress in the aging- associated disorder therapeutics but may also reach a step closer to the edge of ethical concern in the creation of “Frankenstein”.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Novel Stem Cell Techniques:
Innovative applications of cell therapy products (CTPs) derived from the Human Pluripotent Stem Cells (HPSCs) in regenerative medicine are currently being developed. The presence of residual undifferentiated HPSCs in CTPs may be a quality concern related to tumorigenicity. Here, we show a completely particular approach for the direct and sensitive detection of a trace amount of the undifferentiated Human Induced Pluripotent Stem Cells (HiPSCs) having a highly efficient amplification. Essential 8 medium has a better facilitated the expansion of HiPSCs detach into a single cells on laminin-521 than in mTeSR1 medium. Essential 8 medium allowed robust HiPSC proliferation plated on the laminin-521 at low cell density, whereas mTeSR1 didn't enhance the cell growth. HiPSCs cultured on the laminin-521 in Essential 8 medium were assisted in an undifferentiated state and they maintained the ability to differentiate into various cell types.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Stem Cells and Veterinary Applications:
The vegetative cell field is in medicine continues to evolve the rapidly in both experimentally and clinically. Stem cells are most commonly utilized cells in clinical medicine and in therapeutic applications for the treatment of musculoskeletal injuries in horses and dogs. New technologies of assisted reproduction are being developed to use the properties of spermatogonial stem cells to preserve endangered animal species. Equivalent methods are often wont to generate transgenic animals for the production of pharmaceuticals or to be used as biomedical models. Small and enormous animal species functions valuable models for preclinical evaluation of somatic cell applications in citizenry and in veterinary patients in areas like medulla spinals injury and myocardial infraction.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Cancer Stem Cell and Oncology:
Cancer Stem cells CSCs area unit of rare timeless cells within a neoplasm which will hold the overall capability of a natural somatic cell with the flexibility of extremely proliferation and malignancy. They feed the neoplasm development associate degreed to border neoplasm and induce cancer in an organ. These extremely economical qualities of a cancer somatic cell area unit utilized in medication and therapeutic treatments in many diseases Whereas medical specialty outline the study of nature, types, cause, interference and cure of cancer and neoplasm biology.

• Cancer somatic cell and neoplasm Biology

• Cancer genetics and metabolomics

• Radiation medical specialty

• Biomarker in cancer somatic cells

• Novel Cancer stem cell (CSC) regulative Mechanism

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Bone Marrow Transplantation:
Bone marrow is that the soft, spongy tissue inside your bones that creates blood-forming cells (blood stem cells). These cells turn into blood cells including:

• White blood cells to fight infections.

• Red blood cells to carry oxygen throughout the body.

• Platelets to control bleeding.

Blood-forming cells also are found within the blood stream and therefore the duct blood. Before transplantation, we get chemotherapy (chemo) with or without radiation to destroy the diseased blood-forming cells and marrow. Then, healthy cells are given to us (it’s not surgery). The new cells enter your bloodstream through an intravenous (IV) line, or tube. It’s a bit like getting blood or medicine through an IV. The cells find their way into your marrow, where they grow and begin to form healthy red blood cells, white blood cells and platelets.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Cell Therapy for Cardiovascular and Neurological Disorders:
Neural stem cells (NSCs) and neural precursor cells (NPCs) can be isolated from the developing or adult CNS and can be safely expanded in chemically defined culture media for an extended period. The characteristics of restorative capacity and multipotentiality (Figure, A-D) suggest that NSCs may provide an unlimited source of neurons and glia for the treatment of neurologic disorders via cell replacement. Beneficial effects of NSC transplantation have been reported in several animal models of different neurologic diseases such as stroke, spinal cord injuries, Huntington disease, Parkinson disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis. Cell replacement therapy for stroke or spinal cord injury is a bigger challenge because transplanted NSCs need to replace a range of neuronal types, demyelinate axons, and repair complex neural circuitries. As a preliminary step toward this goal, a recent study showed that human fetal–derived NSCs transplanted into the brains of rodents after stroke survived, migrated, and differentiated into various types of neurons and glia.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Biomaterials and Biomedical Applications:
Biomaterials play a major role in medicine today—restoring function and facilitating healing for people after injury or disease. Biomaterials could also be natural or synthetic and are utilized in medical applications to support, enhance, or replace damaged tissue or a biological function. The first historical use of biomaterials dates to antiquity, when ancient Egyptians used sutures made up of animal sinew. The modern field of biomaterials combines medicine, biology, physics, and chemistry, and newer influences from tissue engineering and materials science. The field has grown significantly within the past decade thanks to discoveries in tissue engineering, regenerative medicine, and more.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Stem Cell in Drug Discovery:
As explained Stem Cells area unit general cells that have the aptitude to totally differentiate in to different sort of cells and tissues that area unit the building blocks of body, that's completed by the tactic of regeneration and degeneration which can accustomed overcome the constraints of animal models in bound disorders. Similarly as in drug screening and drug discovery. Several methods area unit accustomed generate such sickness models exploitation either embryonic stem cells (ES cells) or patient-specific induced PSCs (iPSCs), that's making new era within the sector of sickness modelling and drug discovery.

• High thought place screening exploitation iPSCs

• Drug screening

• Upset modelling

• Sickness modelling exploitation iPS cells

• Vegetative cell toxicity testing

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Advances in Stem Cells and their Niches:
The somatic cell niche is that the in vivo microenvironment where stem cells both reside and receive stimuli that determine their fate. Therefore, the niche shouldn't be considered simply a physical location for stem cells, rather because the places where extrinsic signals interact and integrate to influence stem sell behaviour. These stimuli include cell-to-cell and cell-matrix interactions and signals (molecules) that activate and/or repress genes and transcription programs. Stem cells participate in dynamic physiologic systems that dictate the result of developmental events and organismal stress, since these cells are fundamental to tissue maintenance and repair, the signals they receive play a critical role within the integrity of the organism.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Translational Research in Stem Cell Assessments:
The media attention on the sector of stem cells alongside the various successes in animal studies has revealed the necessity to require stock of the moral issues associated with the clinical translation of knowledge about stem cells. In this regard, the authors have dedicated a whole section to translational medicine focusing on cell processing and manufacture, preclinical studies, clinical research, stem cell-based medical innovation, and clinical application. About cell processing and manufacture that are subject to local government agencies’ regulation, the recommendations highlight the need for an accurate, qualified, and independent oversight review process, to guarantee the best integrity, function, and safety of products. The involvement of donors in the procurement of tissue activity should take place after obtaining a valid informed consent as well as after screening for infectious diseases, risk factors, and, where necessary, genetic diseases.

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Cell Biology:
Cells consist of cytoplasm enclosed within a membrane, which also contains many biomolecules such as proteins and nucleic acid. The number of cells in plants and animals varies from species to species, it has been estimated that humans contain somewhere around 40 trillion (4×1013) cells. Enclosing the cell is that the cell envelope – generally consisting of a cell membrane covered by a cell wall which, for a few bacteria, could also be further covered by a third layer called a capsule.

• Eukaryotic cells

• Cytoskeleton

• Genetic material

• Growth and metabolism

• Prokaryotic cells

North & South America: California's Stem Cell Agency| New York Stated Stem Cell Science| The New York Stem Cell Foundation| Stem Cell Network| Brazilian Association of Cellular Therapy

Market Analysis
Stem cells are unique therein they're undifferentiated cells which will differentiate to become virtually any sort of cell within the body (totipotent). They therefore represent an ongoing source of the specialized cells that structure the tissues and organs. there's great interest in stem cells because they need potential to exchange defective or damaged cells resulting from a spread of disorders and injuries, resulting in a variety of latest regenerative therapies. A somatic cell line may be a group of cells that each one descend from one original somatic cell Symmetric division gives rise to 2 identical daughter cells both endowed with somatic cell properties. Asymmetric division produces just one somatic cell and a progenitor cell with limited self-renewal potential.

As a result, this is often likely to contribute to the many growth of the somatic cell market.

Umbilical cord stem cells as a non-invasive and efficacious alternative source of hematopoietic stem cells are gaining added awareness and prevalence.

Moreover, the knowledge regarding the importance of the duct, also as its applications, especially across developed markets, is steadily increasing.

Top Manufacturers/Key-players of Stem Cell Media Market (2021 - 2025): -

â— Thermo Fisher

â— STEMCELL Technologies

â— Merck Millipore

â— Lonza

â— GE Healthcare

â— Miltenyi Biotec

â— Corning

â— CellGenix

â— Takara

â— Promo Cell

Past Conference Report

Stem Cell Congress 2022

With the immense support of Organizing Committee we successfully hosted the 17th World Congress on “Tissue Engineering Regenerative Medicine and Stem Cell Research” was held during October 27-28, 2022 as Webinar. Conference Theme “Exploring Advancements in Stem Cell Research & Tissue Engineering, Regenerative Medicine”

On behalf of Organizing Committee we express our gratitude towards those who helped this conference to be successful one. We are very thankful to all the Attendees, delegates, keynote speakers, plenary speakers, business partners, poster presenter, moderators, chair and co-chair from around the globe.

The conference gave the attendees a pleasant ride through the recent advancement and new technologies delivered for the “Tissue Engineering Regenerative Medicine and Stem Cell Research”. This conference was thankful to its moderators: Avinanda Banerjee Skin Research Institute of Singapore| Singapore. The conference provided beautiful insights in the field of “Tissue Engineering Regenerative Medicine and Stem Cell Research” by marking some remarkable speeches by the speakers

Day 1:

Talk 1 On Title: Two centuries of lactate- pyruvate confusion in cell metabolism: A need to put the anaerobic threshold to rest! by Vadlakonda Lakshmipathi | Kakatiya University | India

Talk 2 On Title: Mechanical characterization and cytotoxicity assessment of porous stainless steel structure for biomedical applications by Niyou Wang | National University of Singapore | Singapore

Talk 3 On Title: Fabricating humans: Ethical, legal and social issues of 3D organ bio printing by Elena Salvaterra | UniCamillus International Medical University | Italy

Talk 4 On Title: Kinematical analysis of hundred meters (100m) sprinters of elite and sub elite level in Pakistan by Majid Fasih and Arslan Zia | University of the Punjab | Pakistan

Talk 5 On Title: Micro-fragmented adipose tissue as a disease targeting stem cell based therapeutic with drug delivery potential in orthopaedic medicine by Mark Slevin | Manchester Metropolitan University | United Kingdom

Talk 6 On Title Nano-fiber hydrogel hybrid synthetic scaffold for controlled glioblastoma growth In vitro by Kalle Levon | New York University Tandon School of Engineering | USA

Talk 7 On Title: From injections to stem cell surgery, minimally invasive joint regeneration in the 21st century by Paul Y F Lee | University of Lincoln | United Kingdom

Talk 8 On Title: Shielding engineered islets with mesenchymal stem cells enhance survival under hypoxia by Bhawna Chandravanshi | Columbia University | USA

E-Poster Presentations On Title: Efficacy of myofunctional training using force sensing resistor on polysomnography, jaw and tongue muscle performance and compliance in elder patients with obstructive sleep apnea by Ching-Wen Hsiao | National Cheng Kung University | Taiwan

E-Poster Presentations on Title: Gluten sensitive patients with steroid-mercury induced rosacea is treatable with cutting-edge ingredient “Hematite: Raw organic extracts of iron minerals” and 0% gluten diet; micro collagen in diet and topically in skin care regimen daily for healthy skin in Caucasians and Asians of all skin type by Nadia Rumman | Cardiff University | United Kingdom

The conference and the attendees were very pleased to have these personalities among themselves as they delivered wonderful speeches in their respective area of researches.

Conference gives proper gratitude to Organizing Committee Members nimble of field various external professionals business enterprise councils and is obliged to different renowned personalities who interlocked with us and bolstered the symposium in each facet without which the convention might now not were possible. And bolstered the symposium in each facet without which the convention might now not were possible. Your reaction is our inspiration; preserving this motto in thoughts and being discovered the triumph of Stem Cells Congress 2022.

The supporting journals include:

• Research and Reports on Genetics

• Journal of Science and Mutation

• Journal of Cell Biology and Metabolism

We welcome all of the famous investigators pupils and delegate partakers to participate on this upcoming convention to witness precious medical discussions and assist to the destiny improvements within the discipline of Tissue Engineering Regenerative Medicine and Stem Cell Research.

A very special Thanks to our Sponsors and Exhibitors to have bestowed and their faith in collaborating with us to make this event a fruitful one. We hope you continue your support in our future endeavours.

Journal of Clinical Medicine an open access journal by MDPI

Conference Series offers its heartfelt appreciation to organizations such as MNT, The Pharma Times, Pharma Voice, Pharma Focus Asia, Select Science, Haptic, Swiss Biotech, JSB Market research, DEPHARM, Pharma Advancement, Course for Doctors and Bio-Equip. We thank our collaborators like Bentham Science, Clinical Biometrics, UK Pharmaco-genetics stratified Medicine network and event listing sites of Dublin and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe.

With the grand success of Stem Cell Congress 2022, Conference Series is proud to announce the "18^th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research" to be held during June 12-13, 2023 at Paris, France around the Theme: "Recent Developments and New Innovations in the field of Stem Cells and Regenerative Medicine".

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 16-17, 2023
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

18^th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research October 16-17, 2023 Paris, France

Recommended Global Genetics & Molecular Biology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Stem Cell Congress - 2023

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues